Oncopeptides AB (publ) (ONPPF) News Today $0.26 0.00 (0.00%) As of 01/13/2025 Add Compare Share Share Headlines Stock AnalysisChart All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Oncopeptides AB (publ) - Special Call TranscriptMarch 6, 2024 | gurufocus.comOncopeptides AB (publ) To Present Updated Ocean Results Call TranscriptMarch 6, 2024 | gurufocus.comOncopeptides enters into a renewed loan facility agreement of up to €30 million with the European Investment BankNovember 25, 2022 | prnewswire.comOncopeptides' Pepaxti has been granted marketing authorization in the UKNovember 11, 2022 | finance.yahoo.comOncopeptides announces the market potential for Pepaxti in EuropeNovember 9, 2022 | finance.yahoo.comOncopeptides publishes Q3 report 2022November 9, 2022 | finance.yahoo.comOncopeptides phase 3 LIGHTHOUSE study further confirms clinical benefit of melflufenOctober 26, 2022 | finance.yahoo.comIssue and re-purchase of class C shares for shareholder program and incentive programOctober 20, 2022 | finance.yahoo.comOncopeptides AB: Oncopeptides starts commercialization of Pepaxti in Europe - Germany first marketOctober 5, 2022 | finanznachrichten.deOncopeptides starts commercialization of Pepaxti in Europe - Germany first marketOctober 3, 2022 | finance.yahoo.comSwedish Biotech’s Cancer Drug Fails With FDA AdvisersSeptember 23, 2022 | finance.yahoo.comOncopeptides provides an update from the meeting with FDAs advisory committee ODACSeptember 23, 2022 | finance.yahoo.comBulletin from an Extra Ordinary General meeting in Oncopeptides AB (publ)September 23, 2022 | finance.yahoo.comBriefing Book for ODAC meeting on benefit/risk profile of Pepaxto now publishedSeptember 20, 2022 | finance.yahoo.comONCO.ST - Oncopeptides AB | Stock Price & Latest News | ReutersSeptember 19, 2022 | reuters.comOncopeptides receives 5 MSEK grant for NK-cell engager project in multiple myelomaSeptember 7, 2022 | finance.yahoo.comEuropean Commission approves Oncopeptides' Pepaxti for the treatment of patients with relapsed refractory multiple myelomaAugust 18, 2022 | finance.yahoo.comOncopeptides AB GAAP EPS of -SEK0.79, revenue of SEK8.8MAugust 13, 2022 | seekingalpha.comOncopeptides publishes Q2 report 2022August 11, 2022 | finance.yahoo.comOncopeptides publishes year-end report 2021February 17, 2022 | finance.yahoo.comInvitation to presentation of 2021 year-end resultsFebruary 14, 2022 | finance.yahoo.comOncopeptides rescinds voluntary withdrawal of Pepaxto in the US - no intent to market in the US at this timeJanuary 21, 2022 | finance.yahoo.comOncopeptides phase 3 OCEAN study published in the Lancet HaematologyJanuary 13, 2022 | finance.yahoo.comOncopeptides announces year-end cash 2021January 5, 2022 | prnewswire.comOncopeptides presents new melflufen data at the Annual American Society of Hematology Meeting ASHDecember 10, 2021 | finance.yahoo.comOncopeptides publishes Q3 2021 reportNovember 24, 2021 | finance.yahoo.comInvitation to presentation of the Q3 2021 resultsNovember 19, 2021 | finance.yahoo.comJakob Lindberg appointed CEO of OncopeptidesNovember 15, 2021 | finance.yahoo.comOncopeptides has announced the Nomination CommitteeNovember 12, 2021 | finance.yahoo.comOncopeptides focuses clinical development efforts to increase cash runwayNovember 4, 2021 | finance.yahoo.comOncopeptides appoints Annika Muskantor as interim CFONovember 1, 2021 | finance.yahoo.comSweden’s Oncopeptides Nosedives After U.S. Treatment WithdrawalOctober 25, 2021 | finance.yahoo.comOncopeptides withdraws Pepaxto® in US, scale down organization and focus on R&DOctober 22, 2021 | finance.yahoo.comOncopeptides' CFO Anders Martin-Löf will leave the companyOctober 15, 2021 | finance.yahoo.comOncopeptides presents phase 3 OCEAN study results at the IMW meetingSeptember 11, 2021 | prnewswire.comInvitation to webcast for presentation of OCEAN data presented at IMWSeptember 9, 2021 | finance.yahoo.comOncopeptides publishes report for Q2 2021August 19, 2021 | finance.yahoo.comOncopeptides' PEPAXTO® Receives a Permanent J-Code, Clarifying Reimbursement Processes in Hospital Outpatient and Physician Office Settings of CareAugust 16, 2021 | finance.yahoo.comInvitation to presentation of the Q2 2021 resultsAugust 12, 2021 | finance.yahoo.comRegulatory update from US Food and Drug AdministrationJuly 28, 2021 | prnewswire.com Get Oncopeptides AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for ONPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address ONPPF Media Mentions By Week ONPPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONPPF News Sentiment▼0.000.78▲Average Medical News Sentiment ONPPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONPPF Articles This Week▼00▲ONPPF Articles Average Week Get Oncopeptides AB (publ) News Delivered to You Automatically Sign up to receive the latest news and ratings for ONPPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AGNPF News AKBLF News DRTSW News APLMW News ARNI News ASPHF News ASCLF News AVCTF News AWKNF News AXIM News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:ONPPF) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncopeptides AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncopeptides AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
